Long-term changes in frailty and incident type 2 diabetes: A prospective cohort study based on the UK Biobank
- PMID: 38783818
- DOI: 10.1111/dom.15676
Long-term changes in frailty and incident type 2 diabetes: A prospective cohort study based on the UK Biobank
Abstract
Aims: To estimate the association between long-term changes in frailty and the risk of incident type 2 diabetes (T2DM) and to evaluate the effect of preventing the worsening of frailty on the risk of T2DM.
Methods: We included 348 205 participants free of baseline T2DM and with frailty phenotype (FP) data from the UK Biobank; among them, 36 175 had at least one follow-up assessment. According to their FP score, participants were grouped into nonfrailty, prefrailty and frailty groups. Frailty assessed at baseline and at follow-up was used to derive the trajectory of frailty (ΔFP). Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: Compared with those in the nonfrailty group at baseline, the HRs of T2DM for the prefrailty and frailty groups were 1.38 (95% CI 1.33-1.43) and 1.69 (95% CI 1.59-1.79), respectively (both p < 0.001), in the multivariable-adjusted model. During a median follow-up of 5.4 years after the final assessment, data for 472 T2DM patients were recorded. A 1-point increase in the final FP was associated with a 25% (95% CI 1.14-1.38; p < 0.001) increased risk of T2DM. For the trajectory of frailty, each 0.5-point/year increase in ΔFP was associated with a 52% (95% CI 1.18-1.97; p < 0.001) greater risk of T2DM, independent of the FP score at baseline. Compared with those that remained in the nonfrailty group, the greatest risk of T2DM over time was prefrailty aggravation (HR 3.03, 95% CI 2.00-4.58; p < 0.001). Using the frailty index did not materially change the results.
Conclusions: Long-term changes in frailty were associated with the risk of incident T2DM, irrespective of baseline frailty status. Preventing the worsening of frailty may reduce T2DM risk.
Keywords: UK biobank; frailty; type 2 diabetes.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Associations Between Frailty and the Increased Risk of Adverse Outcomes Among 38,950 UK Biobank Participants With Prediabetes: Prospective Cohort Study.JMIR Public Health Surveill. 2023 May 18;9:e45502. doi: 10.2196/45502. JMIR Public Health Surveill. 2023. PMID: 37200070 Free PMC article.
-
Association of frailty with the incidence risk of cardiovascular disease and type 2 diabetes mellitus in long-term cancer survivors: a prospective cohort study.BMC Med. 2023 Feb 24;21(1):74. doi: 10.1186/s12916-023-02774-1. BMC Med. 2023. PMID: 36829175 Free PMC article.
-
Associations of Frailty Status and Sleep Quality With Incident Delirium: A Prospective Study in the UK Biobank.CNS Neurosci Ther. 2025 Feb;31(2):e70266. doi: 10.1111/cns.70266. CNS Neurosci Ther. 2025. PMID: 39992050 Free PMC article.
-
Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank.Diabetes Metab. 2022 Nov;48(6):101388. doi: 10.1016/j.diabet.2022.101388. Epub 2022 Sep 16. Diabetes Metab. 2022. PMID: 36122870
-
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD012661. doi: 10.1002/14651858.CD012661.pub2. Cochrane Database Syst Rev. 2018. PMID: 30371961 Free PMC article.
Cited by
-
Association of biological aging acceleration transitions and burdens with incident cardiovascular disease: longitudinal insights from a national cohort study.BMC Med. 2025 Jul 1;23(1):347. doi: 10.1186/s12916-025-04177-w. BMC Med. 2025. PMID: 40598448 Free PMC article.
-
Metabolic profiling of frailty, associations with type 2 diabetes and interaction with genetic susceptibility.Cardiovasc Diabetol. 2025 May 24;24(1):226. doi: 10.1186/s12933-025-02776-8. Cardiovasc Diabetol. 2025. PMID: 40413504 Free PMC article.
-
Causal associations of frailty and type 2 diabetes mellitus: A bidirectional Mendelian randomization study.Medicine (Baltimore). 2025 Mar 7;104(10):e41630. doi: 10.1097/MD.0000000000041630. Medicine (Baltimore). 2025. PMID: 40068076 Free PMC article.
References
REFERENCES
-
- Magliano DJ, Boyko EJ, committee IDFDAtes. IDF Diabetes Atlas. Vol 2021. International Diabetes Federation © International Diabetes Federation; 2021.
-
- Howrey BT, Al Snih S, Markides KS, Ottenbacher KJ. Frailty and diabetes among Mexican American older adults. Ann Epidemiol. 2018;28(7):421‐426.e421.
-
- Aguayo GA, Hulman A, Vaillant MT, et al. Prospective association among diabetes diagnosis, HbA(1c), Glycemia, and frailty trajectories in an elderly population. Diabetes Care. 2019;42(10):1903‐1911.
-
- Simpson FR, Justice JN, Pilla SJ, et al. An examination of whether diabetes control and treatments are associated with change in frailty index across 8 years: an ancillary exploratory study from the action for health in diabetes (look AHEAD) trial. Diabetes Care. 2023;46(3):519‐525.
-
- Li G, Prior JC, Leslie WD, et al. Frailty and risk of fractures in patients with type 2 diabetes. Diabetes Care. 2019;42(4):507‐513.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical